510(k) K252204
K252204 is an FDA 510(k) premarket notification submitted by Prolaio, Inc. for the device "prolaio eVO2peak Module (Version 1.0)". The FDA issued a decision of Substantially Equivalent on Dec 16, 2025. The device falls under product code PPW (Adjunctive Cardiovascular Status Indicator), a Class II device regulated under 21 CFR 870.2200.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 16, 2025
- Date Received
- Jul 14, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Adjunctive Cardiovascular Status Indicator
- Device Class
- Class II
- Regulation Number
- 870.2200
- Review Panel
- CV
- Submission Type
- 510(k)
The adjunctive cardiovascular status indicator is a prescription device based on sensor technology for the measurement of a physical parameter(s). This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
Need the full FDA record for Prolaio, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.